EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-Appropriateness of Oral Formulations Authorized for Pediatrics

Hannah R Weiler, Lauren M Le, Hala M Fadda

Pharmaceutical Research · 2026

DOI: 10.1007/s11095-026-04055-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Hannah R Weiler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, 46208, USA. Hauptthemen laut MEDLINE: Pediatrics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Pediatric global regulatory initiatives have come into place to address gaps in evidence-based medicine for children. Objective of this study was to assess age-appropriateness of oral pediatric formulations authorized through the U.S. Food and Drug Administration’s Pediatric Rule, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act.

Methods

Formulation age-appropriateness was assessed using an adapted version of the World Health Organization pediatric quality product profile assessment tool. Evaluations encompassed four product attributes across pediatric subgroups: dose and dose flexibility, patient acceptability, excipient safety and administration considerations. Each attribute was scored on a three-point scale: 1 indicating high risk, 2 moderate risk, and 3 low risk.

Results

214 oral formulations were evaluated. Age-appropriateness remains a concern; with less than one third of authorized oral formulations for neonates meeting criteria for age-appropriateness, in comparison to 66% for older pediatric populations. Tablets and capsules constitute 58% of formulations indicated for pediatrics, despite tablet sizes often being unsuitable for younger children. Liquid formulations for neonates present a significant oversight, as they frequently contain excipients of potential concern. As children age, swallowability of the dosage form appears to be deprioritized, with only 37% of unswallowable large size tablets for school-aged children, available in alternative dosage forms such as granules, or solids for dispersions.

Conclusions

Significant formulation gaps persist in pediatric medicine, with acceptability and excipient safety presenting highest risk. The potential of non-conventional solid dosage forms remains underutilized, underscoring the need for regulatory frameworks to support development of pediatric medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PediatricsHumansAdministration, OralChildExcipientsTabletsUnited StatesUnited States Food and Drug AdministrationChild, PreschoolChemistry, PharmaceuticalAge FactorsInfantInfant, NewbornDrug CompoundingCapsulesPharmaceutical Preparations

Stichwörter der Autor:innen

WHOchewable tabletsessential medicinesmodified releaseorally disintegrating tablets

Substanzen

ExcipientsTabletsCapsulesPharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, 46208, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, 46208, USA. hfadda@butler.edu.

Zitieren

APA

Weiler, H. R., Le, L. M., & Fadda, H. M. (2026). Age-Appropriateness of Oral Formulations Authorized for Pediatrics. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04055-x

Vancouver

Weiler HR, Le LM, Fadda HM. Age-Appropriateness of Oral Formulations Authorized for Pediatrics. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04055-x

BibTeX
@article{Weiler2026,
  author = {Weiler, Hannah R and Le, Lauren M and Fadda, Hala M},
  title = {Age-Appropriateness of Oral Formulations Authorized for Pediatrics},
  journal = {Pharmaceutical Research},
  year = {2026},
  doi = {10.1007/s11095-026-04055-x}
}
Kostenlos starten →